ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 363979 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 363979; 2) Community: the network communities that were significantly associated with the response to NSC 363979; 3) Molecule: the relationships between components within communities and NSC 363979; 4) MDR: the compounds that were significantly associated with the NSC 363979.

NSC Compound Enrichment Correlation
NSC 319440 Null 0.0467178916101842 -0.11077672
NSC 352741 Null 0.0467178916101842 0.1428495
NSC 362453 Butanedioic acid, mono[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl]ethyl] ester 0.0467178916101842 0.41641529
NSC 123138 Alanine, 3-[(p-chloro-.alpha.,.alpha.-diphenylbenzyl)thio]-, L- (8CI) 0.0483128986658396 0.31514557
NSC 205795 Benzoic acid, 4-[[(2-thiazolylamino)carbonyl]amino]-, ethyl ester (9CI) 0.0483128986658396 -0.098635356
NSC 226080 Sirolimus 0.0483128986658396 0.38900736
NSC 267319 Null 0.0483128986658396 0.1372226
NSC 271967 Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) 0.0483128986658396 0.18838797
NSC 3080 s-Triazine, 4,6-diamino-1-(m-chlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0483128986658396 0.15541191
NSC 332186 Null 0.0483128986658396 0.18501251
Total:57  Current:50    [First] [Prev] [Next] [Last]